SocialyTime SocialyTime
Zoekresultaten
Alle resultaten weergeven
  • Registreer
    Log in
    Creëer je account
    Zoeken
    Night Mode

Zoeken

Ontdek nieuwe mensen, nieuwe verbindingen te maken en nieuwe vrienden maken

  • Nieuws Feed
  • EXPLORE
  • Pagina
  • Groepen
  • Events
  • Blogs
  • Offers
  • Jobs
  • Courses
  • Berichten
  • Blogs
  • Gebruikers
  • Pagina
  • Groepen
  • Events
  • Aryan Mhatre toegevoegd een audio Art
    2026-01-05 12:53:01 -
    Anti-Cancer Drug Market Companies: Growth, Share, Value, Size, and Insights
    "Executive Summary Anti-Cancer Drug Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. The Anti-Cancer Drug report provides CAGR values along with its...
    0 Reacties 0 aandelen 4K Views 0 voorbeeld
    Please log in to like, share and comment!
  • Oddway Pharmaceutical Exporter toegevoegd een audio Health
    2026-04-24 10:07:48 -
    Authentic Gefitinib Tablets IP 250 mg Exporter in Quezon City
    The Philippines requires effective cancer treatment access because Gefitinib Tablets IP 250 mg serve as an important component of targeted therapy. The healthcare industry uses these Gefitinib Tablets because they deliver dependable results which make them suitable for extended treatment needs of patients and their medical teams. Many individuals select Gefitinib Tablets IP 250 mg because they...
    Like
    1
    0 Reacties 0 aandelen 21 Views 0 voorbeeld
    Please log in to like, share and comment!
  • Subhayan Mayra toegevoegd een audio Other
    2026-04-15 11:50:13 -
    Brigatinib API Market Growing at 8.1% CAGR Through 2034 Globally
    According to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...
    0 Reacties 0 aandelen 304 Views 0 voorbeeld
    Please log in to like, share and comment!
  • Subhayan Mayra toegevoegd een audio Other
    2026-04-22 10:26:21 -
    Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034
    According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...
    0 Reacties 0 aandelen 110 Views 0 voorbeeld
    Please log in to like, share and comment!
  • Subhayan Mayra toegevoegd een audio Other
    2026-04-20 11:24:49 -
    Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034
    According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...
    0 Reacties 0 aandelen 148 Views 0 voorbeeld
    Please log in to like, share and comment!
  • Subhayan Mayra toegevoegd een audio Other
    2026-04-13 12:30:06 -
    Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034
    According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...
    0 Reacties 0 aandelen 276 Views 0 voorbeeld
    Please log in to like, share and comment!
  • Oddway Pharmaceutical Exporter toegevoegd een audio Health
    2026-04-22 08:42:22 -
    Reliable Gefitinib Tablets IP 250 mg Source in the Philippines
    Doctors use Gefitinib Tablets IP 250 mg when treating non-small cell lung cancer because the drug specifically targets cancer cells. The Philippine healthcare system requires dependable oncology medications which Gefitinib Tablets IP 250 mg provide to deliver successful treatment results. Healthcare professionals and patients depend on Gefitinib Tablets because it provides them with needed...
    Like
    1
    0 Reacties 0 aandelen 69 Views 0 voorbeeld
    Please log in to like, share and comment!
  • Oddway Pharmaceutical Exporter toegevoegd een audio Health
    2026-04-11 07:58:15 -
    Trusted Gefitinib Tablets Exporter Philippines - Oddway
    Healthcare professionals throughout the Philippines use Gefitinib Tablets as their standard treatment option for non-small cell lung cancer. The consistent availability and high quality of Gefitinib Tablets enable effective cancer treatment at medical facilities. The available Gefitinib Tablets IP 250 mg offer patients an easy way to take their medication through oral administration. The...
    Like
    1
    0 Reacties 0 aandelen 262 Views 0 voorbeeld
    Please log in to like, share and comment!
© 2026 SocialyTime Dutch
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Voorwaarden Privacy Contact Us Bedrijvengids